Mostafa Ebraheem Morra

Mostafa Ebraheem Morra

Auto-generated profile, based on publicly available information

Mostafa Ebraheem Morra

Faculty of Medicine, Al-Azhar University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2018 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
MMMostafa Ebraheem Morra
Mostafa Ebraheem Morra
LTLe Van Thanh
Le Van Thanh
MKMohamed Gomaa Kamel
Mohamed Gomaa Kamel
AGAhmed Abdelmotaleb Ghazy
Ahmed Abdelmotaleb Ghazy
AAAhmed M.A. Altibi
Ahmed M.A. Altibi
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy

5 July 2016 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
MMMostafa Ebraheem Morra
Mostafa Ebraheem Morra
AEAhmed Elgebaly
Ahmed Elgebaly
AEAhmed Elmaraezy
Ahmed Elmaraezy
AKAdham M. Khalil
Adham M. Khalil
AAAhmed M. A. Altibi
Ahmed M. A. Altibi
KHKenji Hirayama
Kenji Hirayama
Several different interventions have been examined to alleviate pain and reduce frequency of trigeminal neuralgia (TN) paroxysms. However, some patients continue to have persistent or recurrent painful attacks. Using a systematic review and meta-analysis approach, we aimed to synthesize evidence from published randomized controlled trials (RCTs) regarding safety and efficacy of botulinum toxin type A (BTX-A) as a possible emerging choice of treatment for TN. We conducted an electronic search in 10 databases/electronic search engines to access relevant publications. All articles in all languages reporting RCTs on the efficacy and safety of BTX-A in the treatment of TN were included for systematic review and meta-analysis. A total of four RCTs (n = 178) were identified for final meta-analysis. The overall effect favored BTX-A versus placebo in terms of proportion of responders (risk ratio RR = 2.87, 95 % confidence interval CI [1.76, 4.69], p <0.0001) with no significant detected heterogeneity (p = 0.31; I2 = 4 %). Paroxysms frequency per day was significantly lower for BTX-A group (mean difference MD = -29.79, 95 % CI [-38.50,–21.08], p <0.00001) with no significant heterogeneity (p = 0.21; I2 = 36 %). Despite limited data, our results suggest that BTX-A may be an effective and safe treatment option for patients with TN. Further larger and well-designed RCTs are encouraged to translate these findings into better clinical outcome and better quality of life for TN patients.

13 May 2017 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
AEAhmed Elmaraezy
Ahmed Elmaraezy
MMMostafa Ebraheem Morra
Mostafa Ebraheem Morra
AMAbdelrhman Tarek Mohammed
Abdelrhman Tarek Mohammed
AAAhmed Al‐Habbaa
Ahmed Al‐Habbaa
AEAhmed Elgebaly
Ahmed Elgebaly
KHKenji Hirayama
Kenji Hirayama

22 November 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MMMostafa Ebraheem Morra
Mostafa Ebraheem Morra
NKNguyen Dang Kien
Nguyen Dang Kien
AEAhmed Elmaraezy
Ahmed Elmaraezy
OAOmar Ayman M. Abdelaziz
Omar Ayman M. Abdelaziz
AEAhmed Lotfy Elsayed
Ahmed Lotfy Elsayed
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy
Leukemia is the most commonly diagnosed childhood cancer, although its etiology is still largely unknown. Growing evidence supports a role for infection in the etiology of acute lymphocytic leukemia (ALL), and the involvement of the immune system suggests that vaccination may also play a role. However, the findings presented in the published literature are inconsistent. Therefore, we conducted a PRISMA systematic review and meta-analysis. 14 studies were identified and meta-analyzed. Vaccinations studied comprised Bacillus Calmette-Guérin (BCG) vaccine, Triple vaccine, Hepatitis B vaccine (HBV), Polio, Measles, Rubella, Mumps, trivalent MMR vaccine and Haemophilus influenza type B (HiB) vaccine. We observed a protective association between any vaccination in the first year of life and risk of childhood leukemia (summary odds ratio (OR) 0.58 [95% confidence interval (CI) 0.36–0.91]). When individual vaccines were analysed, some evidence of an association was seen only for BCG (summary OR 0.73 [95% CI 0.50–1.08]). In conclusion, early vaccination appears to be associated with a reduced risk of childhood leukemia. This finding may be underpinned by the association observed for BCG. Given the relatively imprecise nature of the results of this meta-analysis, our findings should be interpreted cautiously and replicated in future studies.

24 April 2018 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
MMMostafa Ebraheem Morra
Mostafa Ebraheem Morra
AAAhmed M.A. Altibi
Ahmed M.A. Altibi
SISomia Iqtadar
Somia Iqtadar
Minh H. N. LeMinh H. N. Le
Minh H. N. Le
SESameh Samir Elawady
Sameh Samir Elawady
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy
1

1 June 2020 in Physiotherapy
Verified
Journal Article
Closed access
SGSherief Ghozy
Sherief Ghozy
NDNguyen Minh Dung
Nguyen Minh Dung
MMMostafa Ebraheem Morra
Mostafa Ebraheem Morra
SMSara Morsy
Sara Morsy
GEGhadeer Gamal Elsayed
Ghadeer Gamal Elsayed
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy
1